Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John K. Hall
Corrigendum: Muscle-Specific CRISPR/Cas9 Dystrophin Gene Editing Ameliorates Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
613. Characterization of IPSC-Derived Myogenic Progenitors Isolated From Mouse Models of Duchenne Muscular Dystrophy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
Journal of Neuromuscular Diseases
Neurology
Corrigendum: Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Immune Responses to Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Improved Mouse Model for Studying Duchenne Muscular Dystrophy (DMD)
Science-Business eXchange
Muscle Dysfunction in a Zebrafish Model of Duchenne Muscular Dystrophy
Physiological Genomics
Genetics
Physiology
Pathophysiology of Duchenne Muscular Dystrophy: Current Hypotheses
Pediatric Neurology
Child Health
Developmental Neuroscience
Pediatrics
Perinatology
Neurology
Gene Therapy for Duchenne Muscular Dystrophy
Archives of Neurology
Prevention of Muscular Dystrophy in Mice by CRISPR/Cas9-mediated Editing of Germline DNA
Science
Multidisciplinary
Philosophy of Science
History
325. A Novel Utrophin-Based Genome Engineering Strategy for Duchenne Muscular Dystrophy Utilizing Recombinases and CRISPR/Cas9
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
